Higher Volumes, Prices Drive Essity Sales – Nonwovens Industry Magazine

In the first quarter of 2022, Essity’s net sales increased by 24.6% compared to the corresponding period a year ago to reach SEK 34.3 billion ($3.6 billion). Sales growth, including organic sales growth and acquisitions, was 17.3%. Organic sales growth, which excludes currency effects, acquisitions and disposals, was 14.6%, of which volume represented 7.2% and price/mix 7.4%. Organic sales growth in mature markets was 16.5% and in emerging markets 11.6%. Emerging markets represented 37% of net sales. Currency effects increased net sales by 7.4%. Acquisitions increased net sales by 2.7%. Divestments reduced sales by 0.1%.

In the consumer goods segment, net sales rose 21.2% to SEK 21 billion ($2.2 billion). Sales growth, including organic sales growth and acquisitions, was 13.8%. Organic sales growth was 11.5%, of which volume 3.2% and price/mix 8.3%. Organic sales growth was 13.9% in mature markets. In emerging markets, which accounted for 48% of net sales, organic sales growth was 9.1%. Currency effects increased net sales by 7.4%. Acquisitions increased net sales by 2.3%.

In incontinence retail, organic sales growth was 14.6%, in women’s care 21.1% and in baby care 9%. For these three categories, sales growth is mainly the result of higher volumes and price increases. In Consumer Tissue, organic sales growth amounted to 9.9% and for the Consumer Tissue Private Label Europe division to 18.3%. The sales growth is mainly the result of price increases.

In the company’s Healthcare and Medical segment, net sales increased 16.4% to SEK 5.8 billion ($613 million). Sales growth, including organic sales growth and acquisitions, was 11.7%. Organic sales growth was 9.5%, of which volume 7.3% and price/mix 2.2%. Organic sales growth was 6.2% in mature markets. In emerging markets, which accounted for 20% of net sales, organic sales growth was 23.5%. Currency effects increased net sales by 5.2%. Acquisitions increased net sales by 2.2%. Divestments reduced sales by 0.5%.

For Incontinence Products Health Care, organic sales growth was 9.1% due to higher volumes and higher prices. In Medical Solutions, organic sales growth was 10%, mainly driven by higher volumes in wound care and orthopedics.

In professional hygiene, net sales rose 43.7% to SEK 7.5 billion ($793 million). Sales growth, including organic sales growth and acquisitions, was 34.1%. Organic sales growth was 29.8%, of which volume 20.3% and price/mix 9.5%. Organic sales growth amounted to 32.3% in mature markets. In emerging markets, which accounted for 19% of net sales, organic sales growth was 20.8%. Currency effects increased net sales by 9.6%. Acquisitions increased net sales by 4.3%.